UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate

The Journal of nuclear medicine (1978), 2005-01, Vol.46 Suppl 1, p.83S

2005

Volltextzugriff (PDF)

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1652-1659

2010

Volltextzugriff (PDF)

90 Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1652-1659

2010

Volltextzugriff (PDF)

Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with ^sup 90^Y-DOTA^sup 0^,Tyr^sup 3^-Octreotide and ^sup 177^Lu-DOTA^sup 0^,Tyr^sup 3^-Octreotate

The Journal of nuclear medicine (1978), 2005-01, Vol.46, p.83S

2005

Volltextzugriff (PDF)

Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate

The Journal of nuclear medicine (1978), 2005-01, Vol.46 (1 suppl), p.83S

2005

Volltextzugriff (PDF)

Uptake of thymidine labeled on carbon 2: A potential index of liver regeneration by positron emission tomography

Hepatology (Baltimore, Md.), 1990-07, Vol.12 (1), p.113-118

1990

Volltextzugriff (PDF)

Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy

Physics in medicine & biology, 2011-11, Vol.56 (21), p.6759-6777

2011

Volltextzugriff (PDF)

Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma

Neuroendocrinology, 2006-01, Vol.84 (3), p.183-188

2006

Volltextzugriff (PDF)

Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT

European journal of nuclear medicine and molecular imaging, 2009-10, Vol.36 (10), p.1696-1696

2009

Volltextzugriff (PDF)

Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

Clinical gastroenterology and hepatology, 2018-01, Vol.16 (1), p.59-67

2018

Volltextzugriff (PDF)

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

The Journal of nuclear medicine (1978), 2005-01, Vol.46 (1 suppl), p.62S

2005

Volltextzugriff (PDF)

Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings

Seminars in nuclear medicine, 2002-04, Vol.32 (2), p.133-140

2002

Volltextzugriff (PDF)

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

The Journal of nuclear medicine (1978), 2005-01, Vol.46 Suppl 1, p.99S

2005

Volltextzugriff (PDF)

Survival and Response After Peptide Receptor Radionuclide Therapy With [ 90Y-DOTA 0,Tyr 3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors

Seminars in nuclear medicine, 2006-04, Vol.36 (2), p.147-156

2006

Volltextzugriff (PDF)

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs

The Journal of nuclear medicine (1978), 2005-01, Vol.46 Suppl 1, p.92S

2005

Volltextzugriff (PDF)

Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts

European journal of nuclear medicine and molecular imaging, 2011-07, Vol.38 (7), p.1270-1280

2011

Volltextzugriff (PDF)

Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics, (125)Sn-(177)Lu is superior to (90)Y-(177)Lu in peptide receptor radiotherapy

Physics in medicine & biology, 2012-07, Vol.57 (13), p.4263-4275

2012

Volltextzugriff (PDF)

Is bone marrow uptake of 86Y-DOTATOC routinely observed?

European journal of nuclear medicine and molecular imaging, 2011-09, Vol.38 (9), p.1742-1743

2011

Volltextzugriff (PDF)

Is bone marrow uptake of ^sup 86^Y-DOTATOC routinely observed?

European journal of nuclear medicine and molecular imaging, 2011-09, Vol.38 (9), p.1742

2011

Volltextzugriff (PDF)

Evaluation of Novel Whole-Body High-Resolution Rodent SPECT (Linoview) Based on Direct Acquisition of Linogram Projections

The Journal of nuclear medicine (1978), 2005-11, Vol.46 (11), p.1872-1880

2005

Volltextzugriff (PDF)

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide

The Journal of nuclear medicine (1978), 2005-10, Vol.46 (10), p.1696-1700

2005

Volltextzugriff (PDF)

Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics, 125 Sn– 177 Lu is superior to 90 Y– 177 Lu in peptide receptor radiotherapy

Physics in medicine & biology, 2012-07, Vol.57 (13), p.4263-4275

2012

Volltextzugriff (PDF)

Gastrinoma (Duodenal and Pancreatic)

Neuroendocrinology, 2006-01, Vol.84 (3), p.173-182

2006

Volltextzugriff (PDF)

Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics, 125Sn-177Lu is superior to 90Y-177Lu in peptide receptor radiotherapy

Physics in medicine & biology, 2012-06, Vol.57 (13), p.4263-4275

2012

Volltextzugriff (PDF)

Well-Differentiated Gastric Tumors/Carcinomas

Neuroendocrinology, 2006-01, Vol.84 (3), p.158-164

2006

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(105)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(49)
Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Male
(38)
Biological And Medical Sciences
(36)
Medical Sciences
(31)
Female
(27)
Middle Aged
(25)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Adult
(19)
Aged
(16)
Animals
(15)
Octreotide - Analogs & Derivatives
(14)
Investigative Techniques, Diagnostic Techniques
(13)
Radionuclide Investigations
(12)
Octreotide - Therapeutic Use
(11)
Radionuclide Imaging
(11)
Medicine
(10)
Somatostatin - Analogs & Derivatives
(10)
Neuroendocrine Tumors - Radiotherapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

90 Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with ^sup 90^Y-DOTA^sup 0^,Tyr^sup 3^-Octreotide and ^sup 177^Lu-DOTA^sup 0^,Tyr^sup 3^-Octreotate

Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate

Uptake of thymidine labeled on carbon 2: A potential index of liver regeneration by positron emission tomography

Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy

Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma

Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT

Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

Survival and Response After Peptide Receptor Radionuclide Therapy With [ 90Y-DOTA 0,Tyr 3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs

Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts

Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics, (125)Sn-(177)Lu is superior to (90)Y-(177)Lu in peptide receptor radiotherapy

Is bone marrow uptake of 86Y-DOTATOC routinely observed?

Is bone marrow uptake of ^sup 86^Y-DOTATOC routinely observed?

Evaluation of Novel Whole-Body High-Resolution Rodent SPECT (Linoview) Based on Direct Acquisition of Linogram Projections

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide

Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics, 125 Sn– 177 Lu is superior to 90 Y– 177 Lu in peptide receptor radiotherapy

Gastrinoma (Duodenal and Pancreatic)

Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics, 125Sn-177Lu is superior to 90Y-177Lu in peptide receptor radiotherapy

Well-Differentiated Gastric Tumors/Carcinomas

Suchergebnisse filtern